The impact of modified staining method on HER2 immunohistochemical staining for HER2-low breast cancer

被引：2
|
作者：
Chen, Yen-Yin [1 ,2 ,3 ,4 ]
Yang, Ching-Fe [3 ,4 ]
Hsu, Chih-Yi [3 ,4 ,5 ]
机构：
[1] Taipei Med Univ, Shuang Ho Hosp, Dept Pathol, Taipei, Taiwan
[2] Taipei Med Univ, Coll Med, Sch Med, Dept Pathol, Taipei, Taiwan
[3] Natl Yang Ming Chiao Tung Univ, Sch Med, Taipei, Taiwan
[4] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan
[5] Natl Taipei Univ Nursing & Hlth Sci, Coll Nursing, Taipei, Taiwan
来源：
PATHOLOGY | 2024年 / 56卷 / 01期
关键词：
EXPRESSION; FIXATION;
D O I：
10.1016/j.pathol.2023.06.002
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：122 / 124
页数：3
相关论文
共 50 条
  • [11] Evaluation of HER2 scoring algorithms for identification of HER2-low breast cancer
    Costache, S.
    Nagy, A.
    Billingham, K.
    Haynes, H.
    Chefani, A.
    Thomas, T.
    Wedden, S.
    D'Arrigo, C.
    VIRCHOWS ARCHIV, 2020, 477 : S222 - S223
  • [12] HER2-Low Breast Cancer Can Be Visualized by HER2 PET Reply
    Seban, Romain-David
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (11) : 1841 - 1842
  • [13] HER2 cytoplasmic staining and penile cancer
    Silva, Alice M.
    Cunha, Isabela W.
    Guimaraes, Gustavo C.
    Cubilla, Antonio
    Lopes, Ademar
    Soarea, Fernando A.
    CANCER RESEARCH, 2012, 72
  • [14] HER2 Staining Intensity Shows Prognostic Impact on Patients with HER2-Positive Invasive Breast Cancer
    Chen, Yen-Ying
    Hsu, Chih-yi
    MODERN PATHOLOGY, 2018, 31 : 53 - 54
  • [15] HER2 Staining Intensity Shows Prognostic Impact on Patients with HER2-Positive Invasive Breast Cancer
    Chen, Yen-Ying
    Hsu, Chih-Yi
    LABORATORY INVESTIGATION, 2018, 98 : 53 - 54
  • [16] Validation of a fully automated HER2 staining kit in breast cancer
    Moelans, Cathy B.
    Kibbelaar, Robby E.
    van den Heuvel, Marius C.
    Castigliego, Domenico
    de Weger, Roel A.
    van Diest, Paul J.
    CELLULAR ONCOLOGY, 2010, 32 (1-2) : 149 - 155
  • [17] Computational pathology based HER2 expression quantification in HER2-low breast cancer
    Spitzmueller, Andreas
    Kapil, Ansh
    Shumilov, Anatoliy
    Chan, Jessica
    Konstantinidou, Lemonia
    Hassan, Zonera
    Gustavson, Mark
    Carroll, Danielle
    Della Varghese
    James, Gareth D.
    Moh, Akira
    Livingston, Andrew
    de Giorgio-Miller, Victoria
    CANCER RESEARCH, 2023, 83 (05)
  • [18] Think "HER2" different: integrative diagnostic approaches for HER2-low breast cancer
    Marchio, Caterina
    Criscitiello, Carmen
    Scatena, Cristian
    Santinelli, Alfredo
    Graziano, Paolo
    Malapelle, Umberto
    Cursano, Giulia
    Venetis, Konstantinos
    Fanelli, Giuseppe Nicolo
    Pepe, Francesco
    Berrino, Enrico
    De Angelis, Carmine
    Perrone, Giuseppe
    Curigliano, Giuseppe
    Fusco, Nicola
    PATHOLOGICA, 2023, 115 (06) : 292 - 301
  • [19] The frequency of HER2 amplification and the percentage of membrane staining in HER2 2 + invasive carcinomas of the breast
    Andrew H. S. Lee
    Ian O. Ellis
    Virchows Archiv, 2022, 481 : 327 - 327
  • [20] Correlation Study of Four HER2 Immunohistochemical Staining Assays in Breast Cancer and Changes of Heterogeneity Patterns
    Yue, Meng
    Wu, Si
    Huang, Liujing
    Lei, Ming
    Liu, Hongbo
    Wei, Weiwei
    Liu, Yueping
    LABORATORY INVESTIGATION, 2024, 104 (03) : S322 - S324
12345